Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors

摘要

The present disclosure relates to a method of inhibiting angiogenesis comprising administering a N-Acetylated alpha-Linked Acidic Dipeptidase (NAALADase) inhibitor to a patient in need thereof, and a pharmaceutical composition comprising an anti-angiogenic effective amount of a NAALADase inhibitor and a pharmaceutically acceptable carrier.